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An X-ray crystal structure of two N-terminal integrin-binding
IgSF domains of human VCAM-1 is reported. This new crystal
form shows an unusual and highly hydrated packing arrange-
ment in which over 80% of the crystal is occupied by solvent.
The relative orientations of the two domains adopt a new
intermediate conformation. The tilt angle between the two
domains is 19.4, compared with other related structures that
have tilt angles ranging from 7.3 to 39.9. An analysis of the
torsion angles shows that residues Ile88, Tyr89, Ser90, Pro92
and Glu96 play a major role in de®ning the interdomain
conformations.
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1. Introduction
Vascular cell adhesion molecule 1 (VCAM-1/CDM8; Osborn
et al., 1989; INCAM-110; Rice et al., 1990) is a cell-surface
receptor molecule that represents an integrin-binding
subgroup of the immunoglobulin superfamily (IgSF; Wang et
al., 1995). VCAM-1 preferentially binds the integrin hetero-
dimer of the very late antigen (VLA-4) 1 family (Wang &
Springer, 1998) containing 4 (CD49d) and 1 (CD29)
subunits (Vonderheide & Springer, 1992). The VCAM-1±
integrin interaction mediates intercellular adhesion of leuko-
cytes to the blood-vessel wall (Osborn et al., 1989) and also
regulates trans-endothelial emigration at in¯ammatory sites
(Wang & Springer, 1998). VCAM-1 may also act as a host
receptor for viruses and parasites (Huber, 1994), as well as
having important implications in tumour formation and
metastasis (Rice et al., 1990).
The extracellular region of VCAM-1 typically consists of
seven contiguously arranged IgSF domains (VCAM-7D;
Chothia & Jones, 1997) that adopt an extended rod-like
structure (Osborn et al., 1994). Ligand-binding surfaces
speci®c to VLA-4 integrin are exposed on homologous IgSF
domains 1 and 4 of VCAM-7D (Wang & Springer, 1998).
X-ray crystal structures are available for a functional ligand-
binding fragment of domains 1 and 2 of VCAM-1 (Jones et al.,
1995; Wang et al., 1995, 1996) and ligand-binding domains of
related immune-cell adhesion molecules of the subfamily,
including ICAM-1 (Casasnovas et al., 1998; Bella et al., 1998),
ICAM-2 (Casasnovas et al., 1997), MAdCAM-1 (Tan et al.,
1998), CD2 (Jones et al., 1992; Bodian et al., 1994) and CD4
(Brady et al., 1993; Ryu et al., 1994). Here, we present a novel
crystal form of VCAM-1 that adopts a different conformation
and exists in an exceptionally highly hydrated packing
arrangement.
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2. Materials and methods
2.1. Crystallization
Puri®ed protein was a gift from Dr P. Lake. Crystals were
grown at room temperature using the hanging-drop method
and could be obtained using either polyethylene glycol or
ammonium sulfate as the precipitant. Large hexagonal crystals
used for data collection were obtained from 10 ml hanging
drops. These drops comprised 5 ml of protein solution
(10 mg mlÿ1 in 50 mM HEPES buffer pH 7.5) added to a 5 ml
drop of well solution [50 mM Tris buffer pH 7.1, 42%(v/v)
saturated ammonium sulfate].
2.2. Structure determination
A summary of the crystallographic data is given in Table 1.
Crystals of dimensions 1.0  1.0  0.8 mm were mounted in
thin glass Lindemann tubes. X-ray data were collected at room
temperature using a MAR image plate and processed using
DENZO (Otwinowski & Minor, 1993). The structure was
solved by molecular replacement using the program AMoRe
(Navaza, 1994), with one domain of the VCAM structure as
the model (Jones et al., 1995). Positional and B-factor re®ne-
ment were performed using X-PLOR Version 3.1 (BruÈ nger,
1993); water molecules were placed on appropriate peaks in
subsequent difference Fourier maps.
2.3. Density measurements
Aqueous stock solutions of Ficoll 400 (Pharmacia) were
made up at 60, 50, 40, 30, 20 and 10%(w/w). Aliquots of
approximately 40 ml were layered into a glass tube with an
internal diameter of 2 mm. The gradient was calibrated using
5 ml drops of water-saturated chloroform/toluene mixtures.
The calibration solutions were saturated with water and their
density was measured using a 10 ml pycnometer to an esti-
mated accuracy of 0.001 g mlÿ1. The tube with the calibration
droplets was spun at 4000g for 5 min.
3. Results and discussion
3.1. X-ray structure and solvent channels
Statistics for the re®ned structure are given in Table 1. The
packing diagram for this form of VCAM (Fig. 1) shows a
spectacularly large solvent channel with VM = 3.44 AÊ
3 Daÿ1
and over 80% of the crystal being occupied by solvent. In
order to show that lack of electron density in the crystal
channels was indeed arising from solvent and not disordered
VCAM, density measurements of the crystal using the Ficoll
method were carried out.
The single crystal of VCAM which had been used for X-ray
intensity measurements was introduced onto the top of the
Ficoll gradient tube and within 30 s sank to a point corre-
sponding to a crystal density (d) of 1.12 g cmÿ3. After
centrifugation for 5 min at 4000g the crystal sank to a point
corresponding to 1.135 g cmÿ3. The crystal continued to drop
in the gradient tube until stabilizing after about 60 min with an
apparent density of 1.17 g cmÿ3. This increase of crystal
density with time has been commonly observed (Dragovich et
al., 1996; Borgstahl et al., 1996) and is attributed to the
incorporation of Ficoll into the lattice. The number of mole-
cules per unit cell (n) can be calculated from (Westbrook,
1985)
n  NV=Mpc ÿ s=1=p ÿ S;
Table 1
Crystallographic data.
Unit-cell parameters (AÊ ,) a = b = 152.94,
c = 45.98,
 =  = 90,
 = 120
Space group P3121
Z (No. of molecules in the unit cell) 6
dmin (AÊ ) 3.0 (3.05±3.0)
Total No. of observed re¯ections² 183518 (5762)
No. of unique re¯ections² 12530 (622)
Merging R factor² (%) 11.5 (59.6)
Multiplicity² 9.4 (9.3)
Completeness² (%) 99.9 (100)
% > I/3(I)² 74.8 (55.4)
Final R³ (%) 20.8
Final Rfree³ (%) 23.8
R.m.s.d.
Bonds (AÊ ) 0.006
Angles () 1.31
Ramachandran plot
Most favoured region (%) 82.7
Allowed (%) 16.2
Disallowed (%) 1.2
B values (AÊ 2)
Average B value for protein (s.d.) 45.03 (20.81)
Average B value for main chain (s.d.) 42.00 (18.60)
Average B value for side chain (s.d.) 48.20 (22.47)
Average B value for the 50 waters (s.d.) 61.58 (19.56)
² Values in parentheses are for the highest resolution shell of data. ³ R factors were
calculated using all data in the resolution range 24.0±3.00 AÊ .
Figure 1
A highly hydrated packing arrangement in VCAM-1 shown in projection
along c. The unit cell is shown.
where V is the volume of the unit cell (930 600 AÊ 3) and M is
the molecular weight (22 491 Da); c is the measured crystal
density and s is the density of the total solvent compartment.
The protein partial speci®c volume (p) was taken as
0.737 cm3 gÿ1 (Bode & Schirmer, 1985). The initial concen-
tration of the hanging drop was 20% saturated ammonium
sulfate (s = 1.117 g cm
ÿ3). Protein crystals are modelled as a
lattice of solvated protein surrounded by channels of free
solvent (Westbrook, 1985). The calculation of n is very
sensitive to the difference between c and s. With an initial
measured crystal density of
1.12 g cmÿ3, n is calculated to be 11.5,
6.0 and 0.3 for s values of 1.0 (water),
1.07 and 1.117 g cmÿ3 (20% saturated
ammonium sulfate), respectively. The
value of n = 6, required for space
group P3121, is consistent with the
large solvent channels being partially
®lled with ammonium sulfate solution.
This is supported by the crystal-
lographic re®nement, which gives no
trace of connected electron density in the solvent channels.
3.2. Interdomain flexibility
IgSF domains of VCAM-1 and homologous members of the
Ig subfamily are comprised of two antiparallel -pleated
sheets packed face-to-face (Jones, 1993). The common core
structure is stabilized by interconnecting loops and disul®de
bridges (Lesk & Chothia, 1982). A connecting linker peptide
(residues 90±95) mediates the intramolecular dimerization of
VCAM-1 Ig domains, with the last -sheet of domain 1 joining
to the ®rst -sheet of domain 2 (Jones, 1993) (Fig. 2). The
linker peptide mediates interdomain ¯exibility at the hydro-
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Figure 2
MOLSCRIPT representation of VCAM-1. Antiparallel -strands of Ig
domains 1 and 2 (magenta) are stabilized by interconnecting loops (blue).
The structure of VCAM-1 is orientated to reveal the extensive integrin-
binding surface. The key residues involved in basal levels of integrin
binding (cyan; Gln38, Ile39, Asp40, Ser41, Pro42, Leu43, Leu70, Thr72,
Glu87) map to the protruding CD loop and nearby F and G strands of
domain 1. Residues that form speci®c 41 and 47 integrin contacts
(purple; Lys79, Leu80, Glu81, Lys82, Asp143, Ser148, Glu150, Lys152 and
Glu155) reside in domains 1 and domain 2, respectively. The linker
peptide (blue) connects Ig domains 1 and 2. Key linker residues (yellow;
Ile88, Tyr89, Ser90, Phe91, Pro92 and Glu96) proposed to mediate
interdomain movement are shown.
Table 2
Angles () that de®ne interdomain motion of VCAM-1.
Ile88 Tyr89 Ser90 Pro92 Glu96
Name Tilt Skew ’  ’  ’  ’  ’  
VCAM (1ij9) 19.4 77.7 ÿ112.3 162.0 ÿ160.3 151.7 ÿ128.5 120.0 ÿ66.7 ÿ45.5 ÿ121.0 134.0
1vca (A) 39.9 85.5 ÿ109.6 156.9 ÿ164.0 170.1 ÿ144.3 125.7 ÿ77.2 ÿ24.2 ÿ117.3 131.7
1vca (B) 33.9 87.8 ÿ115.9 150.9 ÿ152.3 168.4 ÿ145.5 121.9 ÿ76.4 ÿ22.0 ÿ121.9 129.5
1vsc (A) 16.7 70.8 ÿ131.4 153.2 ÿ150.2 162.2 ÿ146.0 129.1 ÿ82.2 ÿ8.6 ÿ128.0 117.3
1vsc (B) 7.3 55.3 ÿ127.2 149.3 ÿ130.6 153.4 ÿ149.6 119.4 ÿ88.9 ÿ14.2 ÿ134.3 134.1
Figure 3
A MOLSCRIPT stereo overlay of the ®ve known independent
conformations of VCAM-1. The secondary structure of VCAM was
de®ned using the program DSSP. Each of the ®ve VCAM-1 monomers
were superimposed with exclusion of residues 140±149 (C0E loop) and
176±185 (FG loop) to give a structural overlay of domain 2 backbone
atoms. The domain 2 overlay of available VCAM-1 X-ray structures
demonstrates the rigid-body motion of domain 1 relative to domain 2.
Our structural form (magenta) represents an intermediate conformation
of other VCAM-1 structures, 1vsc monomers A and B (green and yellow)
and 1vca monomers A and B (blue and purple).
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phobic interface of domains 1 and 2. The average B factor of
42.0 AÊ 2 (s.d. 18.6 AÊ 2) for main-chain atoms in this structure
solved at room temperature is rather high (Table 1) and only
50 solvent molecules were located. Despite this, the linker
region (residues 88±96) between the two domains is rather
well de®ned and has an average main-chain B factor of 36.4 AÊ 2
(s.d. 4.51 AÊ 2) and slightly more mobile side chains with an
average B factor of 40.4 AÊ 2 (s.d. 12.1 AÊ 2). All ’ and  angles
of this linker are found to lie within the allowed regions of the
Ramachandran plot.
The analysis of dihedral angles measured from all available
structural results (Table 2) suggests that interdomain ¯exibility
is not uniquely determined by the ’, angles of any one linker
residue but is rather determined by changes in the confor-
mation of some or all of the residues in the sequence
Ile88±Glu96. In particular, Ile88, Tyr89, Ser90, Pro92 and
Glu96 play a major role. The ’ angle of Ser90 of ÿ128.5 for
the new VCAM-1 form varies considerably from the narrow
range of values obtained for the other crystal forms (ÿ144.3 to
ÿ149.6). The ’ and  rotation angles of Pro92 of ÿ66.7 and
ÿ45.5, respectively, both deviate from values obtained for the
other four monomers (Table 2). Previous analyses attributed
interdomain ¯exibility to changes in the conformation of the
pivot residue Tyr89 (Wang et al., 1995) or Ile88, Pro92 and
Glu96 (Jones et al., 1995).
A least-squares ®t of main-chain atoms of domain 2 (resi-
dues 96±196) provides an optimized structural alignment for
each of the ®ve crystallographically independent VCAM-1
structures (Table 3; Fig. 3). The `tilt' angle between the
domains (Table 2) is calculated as the angle between the two
lines de®ning the principal axes for each of the domains (Bork
et al., 1996). The tilt angle is essentially two-dimensional and,
in association with the `skew' angle, de®nes the orientation of
the domains. The tilt and skew values obtained for the VCAM
structure presented here (19.4, 77.7) lie between the tilt
(7.3±39.9) and skew (55.3±87.8) angles measured for the
other four monomers. The VCAM structure reported here
adopts a unique conformation, as evident from the tilt and
skew angles which demonstrate projection of domain 1 with
respect to domain 2. This orientation provides an intermediate
VCAM conformation that facilitates interaction of domain 1
with both the ¯exible C0E and FG loops of domain 2.
The torsion angles of the linker residues may in part be
governed by the interdomain contacts. Indeed, the least-
squares ®t of the domains of each of the ®ve structures shows
that there are large differences in the conformations of the
longer FG and C0E loops (Table 3). The inherently mobile C0E
and FG loops located at the hydrophobic interface of Ig
domains 1 and 2 are likely to change conformation in order to
accommodate any changes in the relative positions of domains
1 and 2 (Chothia & Jones, 1997).
3.3. Integrin binding
The current model of integrin binding implicates domain 1
as the critical domain for binding, with domain 2 providing
additional contact residues and conformational stabilization.
Mutagenesis experiments revealed the general integrin-
binding motif of VCAM-1 as the sequence Q38IDSPL located
on the loop connecting -strands C1 and D1 of the ®rst
domain of VCAM-1 (Fig. 2; Newham et al., 1997). Asp40 is a
key integrin-binding residue located at the tip of the CD loop.
It provides a negative charge that may complete a divalent
cation-binding site in the counter-receptor molecule (Jones et
al., 1995). Mutagenesis studies have implicated the sequence
G64NEH exposed on the EF loop in 4 integrin binding to
domain 1 of VCAM-1 (Osborn et al., 1994). The EF loop of
domain 1 lies in close proximity to the CD loop to form a
general integrin-presenting surface (Wang et al., 1996) posi-
tioned near the interface of domains 1 and 2 (Wang et al.,
1995).
Mutational analysis provides the ®rst evidence for the
existence of C0E loop±integrin interactions (Newham et al.,
1997) that support ®ndings of VCAM-1 interdomain contacts.
Residues of the C0E loop (Asp143, Ser148) and E -strand
(Glu150, Lys152 and Glu155) create a negatively charged
surface required for speci®c binding to 47 integrin.
Sequence analysis suggests equivalent negatively charged
residues are a common requirement for 47 binding to
VCAM-1 and MAdCAM-1 (Newham et al., 1997). Speci®c
integrin binding of 41 to VCAM-1 maps to residues
K(79)LEK that reside in the G -strand of domain 1 (Kilger et
al., 1997) (Fig. 2).
The structural data presented here provides further insight
into the mechanism of adhesive interactions in the Ig
subfamily of integrin-binding proteins. The conformation of
our X-ray crystal structure demonstrates interdomain motion
stabilized by the extensive loops of domain 2.
We thank Dr P. Lake from Sandoz AG for providing
protein.
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